US regulators approved GSK Plc’s blood cancer drug, a decision that will allow the company to bring the medicine back to the ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who ...

Researchers believe they have developed the first dedicated blood test to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), which has the potential to be a ...

Emory researchers discovered blood changes that could allow Alzheimer’s to be detected years before symptoms appear. The team is developing a blood test that may identify early risk and guide ...

Scientists at the University of East Anglia and Oxford Biodynamics have developed a high accuracy blood test to diagnose chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME/CFS). The ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Our bodies do not age at a uniform rate. The speed at which one organ ages can differ greatly from another due to a range of lifestyle, environmental and genetic factors. Conventional tests provide a ...

The first hints that Gregory Nelson might be having cognitive troubles were subtle. So subtle, in fact, that his doctor assured him nothing was wrong. “Everyone who hits a certain age just misses ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. The first hints that Gregory Nelson might ...

Scientists discovered that certain blood proteins linked to brain injury and inflammation strongly correlate with early signs of memory and cognitive decline, especially in Hispanic and Latino adults.